Lv1
54 积分 2024-09-06 加入
The Life Cycle and Management of Protocol Deviations
15小时前
已完结
CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial
7天前
已完结
Type 2 diabetes mellitus
2个月前
已完结
Mesenchymal stem cell therapy for type 2 diabetes: mechanisms, clinical evidence, and future directions
2个月前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
2个月前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
2个月前
已完结
Stem cell therapies for diabetes
2个月前
已完结
Mesenchymal stem cell therapy for diabetes: An umbrella review
2个月前
已完结
Dose‐proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase‐4 inhibitor, in healthy volunteers
7个月前
已完结
皖公网安备34019202002308
